Related Experiment Video
Updated: May 12, 2026
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
[Treatment of nasopharyngeal carcinoma in children]
Wei-Wei Liao1, Suo-Qin Tang, Ying Liu
1Department of Pediatrics, General Hospital of People's Liberation Army, Beijing, China.
Insights
The ARAR0331 protocol shows promise for treating childhood nasopharyngeal carcinoma, achieving high remission and survival rates with manageable side effects in a small study.
Area of Science:
- Pediatric Oncology
- Cancer Treatment Protocols
Background:
- Childhood nasopharyngeal carcinoma (NPC) is rare.
- Effective treatment protocols are crucial for improving outcomes.
Purpose of the Study:
- To evaluate the clinical efficacy and safety of the ARAR0331 protocol for pediatric nasopharyngeal carcinoma.
Main Methods:
- Retrospective analysis of eight pediatric NPC patients (May 2004-May 2012).
- Seven patients received the ARAR0331 protocol; one received standard chemotherapy and radiotherapy.
- Patient demographics and treatment outcomes were assessed.
Main Results:
- Four of seven patients on the ARAR0331 protocol achieved complete remission; two achieved partial remission.
- 100% survival rate observed in the seven patients treated with ARAR0331 over 8-75 months follow-up.
- Treatment-related toxicities included radiodermatitis, mucositis, and nausea; no late toxicity was reported.
Conclusions:
- The ARAR0331 protocol demonstrates effectiveness and safety in treating childhood nasopharyngeal carcinoma.
- Further research with larger cohorts is warranted to confirm these findings.
Objective:
To evaluate the clinical efficacy of the ARAR0331 protocol for treatment of childhood nasopharyngeal carcinoma.
Methods:
The clinical data of eight children with nasopharyngeal carcinoma between May 2004 and May 2012 were retrospectively studied. The eight patients included six boys and two girls, and the onset age was between 3 and 13 years. Six patients were in AJCC Stage Ⅲ, one was in StageⅡA and one was in Stage ⅣA. One patient had been treated with combined radiotherapy and chemotherapy which mainly included EAP, BEP and EA. The other seven patients had been treated with the ARAR0331 protocol provided by the America Children's Oncology Group (COG).
Results:
The patient who had been treated with combined radiotherapy and chemotherapy developed multiple bony metastasis during the chemotherapeutic period. Four out of seven patients who had been treated with ARAR0331 protocol achieved complete remission, and two achieved partial remission. The seven patients were followed-up from 8 to 75 months and the survival rate was 100%. The ARAR0331 protocol treatment-related complications included radiodermatitis, mucocitis and nausea. Late toxicity was not found.
Conclusions:
Based on the limited cases, ARAR0331 protocol appears to be effective and safe for childhood nasopharyngeal carcinoma.
Related Concept Videos
01:29Suctioning the Nasopharyngeal Airway
Equipment Required
02:56Treatment Resistant Cancers
01:30Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:26Tonsillitis II: Management